NYSE - Delayed Quote • USD
Taro Pharmaceutical Industries Ltd. (TARO)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 4:02 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | -- |
| Avg. Estimate | 0.31 | 0 | 1.1 | 0 |
| Low Estimate | 0.31 | 0 | 1.1 | 0 |
| High Estimate | 0.31 | 0 | 1.1 | 0 |
| Year Ago EPS | 0.18 | 0.27 | 0.68 | 1.1 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | -- |
| Avg. Estimate | 156.06M | -- | 618.06M | -- |
| Low Estimate | 156.06M | -- | 618.06M | -- |
| High Estimate | 156.06M | -- | 618.06M | -- |
| Year Ago Sales | 146.59M | -- | 572.95M | 618.06M |
| Sales Growth (year/est) | 6.50% | -- | 7.90% | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.23 | 0.31 | 0.18 | 0.3 |
| EPS Actual | 0.18 | 0.27 | 0.23 | 0.54 |
| Difference | -0.05 | -0.04 | 0.05 | 0.24 |
| Surprise % | -21.70% | -12.90% | 27.80% | 80.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.31 | 0 | 1.1 | 0 |
| 7 Days Ago | 0.31 | 0 | 1.1 | 0 |
| 30 Days Ago | 0.31 | 0 | 1.1 | 0 |
| 60 Days Ago | 0.31 | 0 | 1.1 | 0 |
| 90 Days Ago | 0.31 | 0 | 1.1 | 0 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | TARO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 72.20% | -- | -- | 1.50% |
| Next Qtr. | -- | -- | -- | 11.40% |
| Current Year | 61.80% | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.40% |
| Next 5 Years (per annum) | -12.95% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -33.80% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 1/18/2024 |
| Maintains | HC Wainwright & Co.: Buy | 1/25/2023 |
| Maintains | HC Wainwright & Co.: Buy | 8/15/2022 |
| Maintains | HC Wainwright & Co.: Buy | 1/31/2022 |
| Maintains | HC Wainwright & Co.: Buy | 1/18/2022 |
| Maintains | HC Wainwright & Co.: Buy | 7/28/2021 |
Related Tickers
REKA.TA Rekah Pharmaceutical Industry Ltd.
1,367.00
+2.32%
LFCR Lifecore Biomedical, Inc.
6.33
-1.86%
KMDA Kamada Ltd.
5.18
+1.57%
COLL Collegium Pharmaceutical, Inc.
35.48
-1.28%
PBH Prestige Consumer Healthcare Inc.
70.13
-1.53%
SUNPHARMA.NS Sun Pharmaceutical Industries Limited
1,485.75
+0.07%
RDY Dr. Reddy's Laboratories Limited
70.92
-0.80%
ESAIY Eisai Co., Ltd.
10.15
+3.05%
EVO Evotec SE
5.23
-32.95%
ALKS Alkermes plc
24.65
+1.61%